Cluster analysis showed that an early increase in the levels of Parkinson disease protein 7 (PARK7), vimentin, myeloperoxidase (MPO), CD69, and NF-κB essential modulator (NEMO) in plasma is related to a decrease in ROP risk. Here, PARK7 is linked to retinopathy of prematurity.